✦ LIBER ✦

P599 Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease

✍ Scribed by de Carpi, J. Martín; Llerena, E.; Vila, V.; Pinillos, S.; Varea, V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P578 Adalimumab as first-line anti-TNF t

✍ Martín-de-Carpi, J.; Navas-Lopez, V.M.; Navalón-Rubio, M.; Llerena-Santa-Cruz, E 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 55 KB

P-087: Adalimumab as first-line anti-TNF

✍ Martín-de-Carpi, J.; Navas-López, V.M.; Navalon-Rubio, M.; Llerena-Santa-Cruz, E 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Tu1194 Adalimumab As First-Line Anti-TNF

✍ Martín-de-Carpi, Javier; Navas-López, Victor; Navalón-Rubio, María; Llerena-Sant 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P211 - Efficacy of adalimumab in paediat

✍ J. Martín de Carpi; N. Pociello; S. Pinillos; K. Chávez; P. Vilar; V. Varea 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

First-line therapy in adult Crohn's dise

✍ Peyrin-Biroulet, Laurent; Fiorino, Gionata; Buisson, Anthony; Danese, Silvio 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 401 KB

P-105: Anti-TNF for the prevention of po

✍ Martín-de-Carpi, J.; Pujol, G.; Vila, V.; Pinillos, S.; Tarrado, X.T.; Varea, V. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 54 KB